News
Press releases
Vicore Expands and Strengthens its Board of Directors
14 May 24
Biotech, News, Press Releases
Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock
10 May 24
Press Releases
Merrimack Pharmaceuticals, Inc. Announces Anticipated Final Cash Dividend Amount of Initial Liquidating Distribution, Subject to Receipt of Stockholder Approval of Plan of Dissolution
9 May 24
Press Releases
Merrimack Pharmaceuticals Announces Notification of Plan to Voluntary Delist Common Stock on NASDAQ Subject to Receipt of Stockholder Approval of Plan of Dissolution
30 Apr 24
Press Releases
Merrimack Receives $225 Million Milestone Payment from Ipsen
27 Mar 24
Press Releases